Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/15/2009WO2009103959A3 Histidine and/or histidine derivative for the treatment of inflammatory skin diseases
10/15/2009WO2009103150A4 Method for treating migraine headaches
10/15/2009WO2009102240A3 Medicinal agent for treating oncological diseases
10/15/2009WO2009100323A3 Methods of using carboxylic amides as antimicrobial agents
10/15/2009WO2009099942A3 Chemically modified oligonucleotides and uses thereof
10/15/2009WO2009099563A3 Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease
10/15/2009WO2009098715A3 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
10/15/2009WO2009097228A3 Composition and method for treating and preventing musculoskeletal and connective tissue disorders
10/15/2009WO2009096908A3 Extended-release fluvastatin tablet
10/15/2009WO2009095798A3 Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
10/15/2009WO2009095712A3 4-(3-amin0pyraz0le) pyrimidine derivatives for use as jak kinase inhibitors in the treatment of cancer
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009WO2009091967A3 Fenofibric acid polymorphs; methods of making; and methods of use thereof
10/15/2009WO2009090210A3 Combination of metformin and an mtp inhibitor
10/15/2009WO2009089366A3 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators
10/15/2009WO2009089284A3 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist
10/15/2009WO2009087667A3 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions
10/15/2009WO2009086123A8 Imidazo [1,2-a] pyridine compounds
10/15/2009WO2009078931A9 Irf as a tumor suppressor and uses thereof
10/15/2009WO2009073148A3 Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
10/15/2009WO2009072062A3 Derivatives of dihydroxypyrrolidine as anti- cancer compounds
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009065600A3 Means for treating myosin-related diseases
10/15/2009WO2009063378A3 Olive oil formulation for pain relief
10/15/2009WO2009062193A3 Methods for administering corticosteroid formulations
10/15/2009WO2009059765A3 Process for the preparation of drospirenone
10/15/2009WO2009059047A3 Tricyclic compounds and methods for using the same
10/15/2009WO2009056811A3 Tetrahydrobenzothiazole derivatives with dopamine receptor activity
10/15/2009WO2009054725A3 Means and methods for counteracting muscle disorders
10/15/2009WO2009052454A3 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
10/15/2009WO2009050554A3 Pyrazolo [4, 3d] pyrimidine derivatives for use in promoting functional recovery
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009WO2009047794A3 Docetaxel injectable composition, being absolutely free of ethanol
10/15/2009WO2009047779A3 Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
10/15/2009WO2009043926A3 Oral fast disintegrating tablets
10/15/2009WO2009042138A9 Alkylthio pyrimidines as crth2 antagonists
10/15/2009WO2009019138A3 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009WO2009015000A8 Pyrazole urea derivatives used as kinase inhibitors
10/15/2009WO2008145996A3 Novel compounds and pharmaceutical preparations from neobeguea spec
10/15/2009WO2008129501A3 Pharmaceutical compositions of duloxetine
10/15/2009WO2008129465A9 Stable pharmaceutical compositions of bupropion
10/15/2009WO2007017897A3 Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
10/15/2009US20090260094 Stearoyl-CoA Desaturase 4 Gene
10/15/2009US20090259228 Methods for Preventing Posterior Capsular Opacification
10/15/2009US20090259167 Methods and compositions for dose-dependent photodynamic therapy of disorders
10/15/2009US20090259166 Systems and Methods for Transdermal Photo-Polymerization
10/15/2009US20090259047 contacting (S)-omeprazole freebase or its sodium/potassium salt with inorganic or organic acid salt of the barium (barium chloride, barium sulfate, barium oxalate, barium acetate) in a suitable solvent ( methanol)in presence of a base ( NaOH) to form (S)-omeprazole barium; helicobacter infections
10/15/2009US20090259043 Tricyclic cytoprotective compounds
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258952 Patch containing anti-inflammatory agent
10/15/2009US20090258951 Use of vanillyl alcohol for the treatment of Parkinson's disease
10/15/2009US20090258949 Amorphous form of cinacalcet
10/15/2009US20090258948 Pharmaceutical salts
10/15/2009US20090258947 Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
10/15/2009US20090258946 Electrostatically charged nasal application multipurpose products and method
10/15/2009US20090258945 Lipoxin Compounds and Their Use in Treating Cell Proliferative Disorders
10/15/2009US20090258944 Method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewith, and their use
10/15/2009US20090258942 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/15/2009US20090258941 Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases
10/15/2009US20090258940 American cranberry extract and its use
10/15/2009US20090258939 Pyrone analog compositions and methods
10/15/2009US20090258938 Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans
10/15/2009US20090258937 Methods for Modulating Tumor Growth and Metastasis
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258934 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
10/15/2009US20090258933 Oligonucleotides-transferring preparations
10/15/2009US20090258932 Lyophilized DNA Formulations for Enhanced Expression of Plasmid DNA
10/15/2009US20090258931 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
10/15/2009US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same
10/15/2009US20090258929 Compositions and Methods for Modulating mTOR Signaling
10/15/2009US20090258928 Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
10/15/2009US20090258927 Method for the Modulation of Function of Transcription Factors
10/15/2009US20090258926 Methods and Compositions for Delivering siRNA into Mammalian Cells
10/15/2009US20090258925 Natural antisense and non-coding rna transcripts as drug targets
10/15/2009US20090258924 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES
10/15/2009US20090258923 Carrier Composition for Nucleic Acid Transport
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258921 Indole derivatives
10/15/2009US20090258920 Injectable formulation of antibiotic and solution for intravenous administration thereof
10/15/2009US20090258919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258917 Benzoxazoles Useful in the Treatment of Inflammation
10/15/2009US20090258915 Ribonucleotide reductase inhibitors and methods of use
10/15/2009US20090258914 Inhibitor of Anti-Apoptotic Proteins
10/15/2009US20090258913 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
10/15/2009US20090258911 Composition and method for treating fibrotic diseases
10/15/2009US20090258910 benzo[1,3]dioxol-5-yl-carbamic acid 6-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester and benzo[1,3]dioxol-5-yl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester;
10/15/2009US20090258909 Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS)
10/15/2009US20090258908 Crystalline S-Omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
10/15/2009US20090258907 Compounds useful as inhibitors of rock kinases
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258905 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/15/2009US20090258904 Epithiolone Analogues
10/15/2009US20090258903 Aminoethane Sulfonamide Orexin Receptor Antagonists
10/15/2009US20090258902 Biphenyl-pyrazolecarboxamide compounds
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
1 ... 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 ... 7860